6,555 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Acquired by Himension Capital Singapore PTE. LTD.

Himension Capital Singapore PTE. LTD. acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,555 shares of the company’s stock, valued at approximately $868,000.

Other institutional investors have also added to or reduced their stakes in the company. Steward Partners Investment Advisory LLC increased its stake in shares of Astera Labs by 99.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock valued at $26,000 after purchasing an additional 99 shares during the last quarter. Whittier Trust Co. of Nevada Inc. acquired a new stake in Astera Labs in the fourth quarter valued at about $25,000. Kestra Investment Management LLC bought a new position in Astera Labs in the fourth quarter valued at about $28,000. GAMMA Investing LLC grew its position in Astera Labs by 78.3% in the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock valued at $68,000 after acquiring an additional 224 shares during the last quarter. Finally, CIBC Asset Management Inc raised its stake in Astera Labs by 5.2% during the fourth quarter. CIBC Asset Management Inc now owns 4,757 shares of the company’s stock worth $630,000 after acquiring an additional 237 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Jitendra Mohan sold 350,680 shares of the business’s stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total value of $31,389,366.80. Following the completion of the sale, the chief executive officer now directly owns 2,353,655 shares of the company’s stock, valued at $210,675,659.05. The trade was a 12.97 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Michael E. Hurlston sold 2,500 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total value of $230,200.00. Following the completion of the transaction, the director now owns 91,794 shares in the company, valued at approximately $8,452,391.52. The trade was a 2.65 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 633,990 shares of company stock worth $54,235,012.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $52.94 on Friday. The business’s 50-day moving average is $78.49 and its 200-day moving average is $90.74. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39. The company has a market capitalization of $8.58 billion and a price-to-earnings ratio of -30.60.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. Analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Ratings Changes

ALAB has been the topic of several recent research reports. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price objective on the stock in a report on Tuesday, January 28th. Morgan Stanley reduced their price target on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 28th. Needham & Company LLC reiterated a “buy” rating and set a $140.00 target price on shares of Astera Labs in a research report on Tuesday, February 11th. Raymond James started coverage on shares of Astera Labs in a research report on Friday, March 14th. They issued an “outperform” rating and a $82.00 price target for the company. Finally, Stifel Nicolaus lifted their price target on shares of Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $112.77.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.